Find your next role
Strengthen your profile
This role is for a VP Corporate Controller at Immunic, responsible for leading the accounting function during the transition to commercial operations. You will oversee gross-to-net revenue accounting, internal controls, and SEC reporting, while building the finance infrastructure needed for the anticipated U.S. product launch.
Immunic Therapeutics
See how your profile stacks up against this role.
We compared the job requirements to your profile to show where you're strong and where you fall short.
Summary
We are seeking a VP Corporate Controller to lead our accounting function as Immunic transitions from clinical-stage development to commercial operations.
Reporting to the Executive VP of Finance, you will lead the accounting team and own the close, SEC reporting, internal controls and gross-to-net revenue accounting, partnering closely with Commercial, Market Access and Trade/Distribution.
You will join us as we build the finance infrastructure, controls, systems and team needed for the anticipated U.S. launch of our first product. The ideal candidate combines deep commercial-stage gross-to-net expertise with a hands-on, builder mindset and must be based on the east coast with direct biotech experience through Phase III.
Responsibilities
Design, implement and own gross-to-net (GTN) revenue accounting for our first commercial product, including reserves for chargebacks, rebates (commercial, Medicaid, Medicare Part D, 340B), distribution and data fees, co-pay assistance, returns and prompt-pay discounts.
Develop audit-ready GTN estimation methodologies, roll-forwards and true-up processes, applying ASC 606 variable consideration principles.
Partner with Market Access, Trade and Government Pricing to align contract terms, channel data and government pricing calculations (AMP, Best Price, ASP, Non-FAMP) with accounting.
Establish inventory accounting and costing (ASC 330), including pre-launch inventory capitalization, standard costing, CMO/3PL reconciliations and excess/obsolescence reserves.
Lead the monthly, quarterly and annual close, including clinical trial accruals, stock-based compensation, leases and other technical areas.
Prepare and review Forms 10-Q and 10-K, footnotes and supporting schedules in partnership with the CFO and SEC reporting resources.
Design and maintain a SOX-compliant internal control environment, scaling controls for new commercial processes (order-to-cash, GTN, inventory, procure-to-pay).
Serve as primary liaison with external auditors for quarterly reviews and the annual audit, and prepare technical accounting memos (with external consultants as needed) for new transactions and commercial arrangements.
Support the selection and implementation of a commercial-ready ERP and related systems, including GTN/revenue management and 3PL integrations.
Build, lead and develop a high-performing accounting team, manage outsourced accounting partners, and partner with FP&A on budgeting, forecasting and launch-related financial analysis.
Qualifications & Education
Bachelor’s degree in Accounting; CPA (active or inactive) required.
10+ years of progressive accounting experience, including Big 4 public accounting and public-company industry experience.
Direct, hands-on gross-to-net accounting experience at a commercial-stage pharmaceutical or biotechnology company, including establishing or managing GTN reserves and accruals.
Strong knowledge of U.S. GAAP (particularly ASC 606 and ASC 330), SEC reporting requirements and SOX 404 compliance, including designing internal controls.
Demonstrated ability to lead a close process and to manage and develop staff.
Excellent communication skills and the ability to partner cross-functionally with commercial and operational teams.
A builder mindset: hands-on, detail-oriented and strategic, with high integrity, sound judgment and strong ownership in a fast-paced, evolving environment.
Experience with Oracle NetSuite as an end user or administrator, ideally including a key role in a NetSuite implementation at a life sciences company preparing for commercialization, preferred.
Experience with Workiva for SEC reporting (10-Q/10-K, XBRL tagging) preferred.
Experience with a product launch, building commercial accounting processes from the ground up, preferred.
Familiarity with government pricing, the Medicaid Drug Rebate Program, 340B and specialty distribution models preferred.
Experience with GTN/contract management systems (e.g. Model N, IntegriChain, Revitas) preferred.
Immunic Therapeutics is an Equal Opportunity Employer. We are committed to fostering a diverse, inclusive, and equitable workplace where all individuals are valued and respected. Employment decisions are based on qualifications, merit, and business needs, without regard to race, color, religion, gender, sexual orientation, national origin, disability, veteran status, or any other protected status.
Please note, Immunic does not accept unsolicited resumes from external agencies or recruiters. Submission of a resume without a prior written agreement does not create any express or implied contract between Immunic and the agency. Immunic will not pay any fees related to unsolicited resumes.
Vice President of Builder & Developer Sales
Savant Systems · Today
Remote from United States, Massachusetts (USA) · Full time
Vice President, Life Sciences Strategy Consulting
Kx Advisors · Today
Remote from United States, District of Columbia (USA), Massachusetts (USA), New York (USA) · Full time
Vice President of Information Security and Infrastructure
American College of Education · 7 days ago
Remote from United States, Alabama (USA), Alaska (USA), District of Columbia (USA), Massachusetts (USA), South Dakota (USA) · Full time
Vice President- AI, Center of Excellence
Mastercard · 30+ days ago
Remote from United States, California (USA), Delaware (USA), Florida (USA), Georgia (USA), Massachusetts (USA), Missouri (USA), Nebraska (USA), New York (USA), Washington (USA) · Full time
Vice President- AI, Center of Excellence
Minna Technologies · 30+ days ago
Remote from United States, California (USA), Delaware (USA), Florida (USA), Georgia (USA), Massachusetts (USA), Missouri (USA), Nebraska (USA), New York (USA), Washington (USA) · Full time

Immunic Therapeutics

Immunic Therapeutics

Immunic Therapeutics